biotech.today

Details

  • ●Modalities: diagnostics, multi-modal assays
  • ●Therapeutic areas: oncology
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $62M

Partners & investors

  • Founders Fund· Investor
  • Section 32· Investor
  • a16z· Investor

Key considerations

  • ●AI tools in use: Enable Platform
  • ●$62M Series A (2023)
  • ●Founders Fund, a16z, Section 32 backing
Get live updates on Enable Medicine’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Alex Carlisle

Co-Founder & CEO

spatial-biology
Visit website →LinkedIn →